® magazine, which serves over a million patients, survivors and caregivers dedicated to providing cancer updates, has announced they are accepting submissions to the 

® Art Gallery to be featured as the cover art for an upcoming issues of 

“We are excited to feature reader art on a future cover of 

® magazine,” said Michael J. Hennessy Jr., president of MJH Associates, parent company of CURE Media Group. “This provides a unique opportunity for our readers to express themselves through art and share their talents with 

®’s audience of more than 1 million readers.”

All readers are encouraged to submit their art for the contest via the 

® Art Gallery. First, they can create any kind of original visual art, such as paintings, sketches, etc. Next, participants can submit their art at 

 along with a short description of the piece. Designs will be posted in the online art gallery and may be featured in future issues of 

The deadline to submit artwork for the Cover Contest is Aug. 15, 2019, after which one artist’s submission will be selected to feature on the front cover of a future 

Those readers who don’t wish to participate in the Cover Contest but still wish to submit artwork are encouraged to do so throughout the year for the chance to be featured in print or online.

CURE Media Group is the leading resource for cancer updates, research and education. It combines a full suite of media products, including its industry-leading website, 

; innovative video programs, such as “CURE Connections®”; a series of widely attended live events; and 

® magazine, which reaches over 1 million readers, as well as the dynamic website for oncology nurses, 

. CURE Media Group is part of the Cranbury, New Jersey-based MJH Associates, Inc. family of businesses, which includes the acclaimed 

platform of resources for the practicing oncologist. For more information, visit 

Articles

One artist will be selected to have their artwork featured on a future cover of CURE® magazine.

CURE Media Group Seeks Submissions for CURE Magazine Cover Contest

® magazine, which services over a million patients, survivors and caregivers dedicated to providing cancer updates, has opened nominations for its 2020 Extraordinary Healer® Award for Oncology Nursing. This annual honor recognizes oncology nurses who have made great strides in the field of oncology or demonstrated commendable compassion in patient care.

“We are excited to be accepting nominations for next year’s Extraordinary Healer® Award for Oncology Nursing,” said Michael J. Hennessy Jr., president of MJH Associates, parent company of CURE Media Group. “We’re looking forward to honoring another exceptional oncology nurse who makes a positive impact in the lives of their patients.”

Nominations will be accepted through Jan. 1, 2020, and can be submitted by current and former patients, caregivers or peers in the form of a 700- to 1,000-word essay that should reflect the candidate’s outstanding contributions to the field of oncology or in a patient’s life. The selection committee will choose three finalists, who will be honored at a gala reception held in conjunction with the Oncology Nursing Society’s 45th Annual Congress, which will take place in spring 2020 in San Antonio, Texas. One nurse ultimately will be recognized with the 2020 Extraordinary Healer® Award for Oncology Nursing.

For more information about the 2020 Extraordinary Healer® Award for Oncology Nursing reception and to submit a nomination online, click

. CURE Media Group is part of the Cranbury, New Jersey-based MJH Associates, Inc., family of businesses, which includes the acclaimed 

CURE® magazine, which services over a million patients, survivors and caregivers dedicated to providing cancer updates, has opened nominations for its 2020 Extraordinary Healer® Award for Oncology Nursing. Nominations will be accepted through January 1, 2020.

CURE Media Group Seeks Nominations for the 2020 Extraordinary Healer Award for Oncology Nursing

CURE Media Group’s flagship product, CURE® magazine, which services over a million patients, survivors and caregivers dedicated to providing cancer updates, proudly announces Barbara Bittner, RN, OCN; Caitlin Cohen, M.S.N., RN, CPNP-AC, CPHON; and Angela Hammack, B.S.N., RN, OCN, as the three finalists for the 2019 Extraordinary Healer

“All three of these finalists have demonstrated an incredible passion for caring for cancer patients. They have gone above and beyond what is asked of them, and we are honored to recognize them for their contributions,” said Michael J. Hennessy Jr., president of MJH Associates, parent company of CURE Media Group.

The finalists for the 2019 Extraordinary Healer® Award for Oncology Nursing — all registered nurses &mdash; are:

has 34 years of nursing experience and works as a navigator for AdventHealth New Smyrna Beach, where she the evaluates the physical and mental health of patients with cancer and shares advice with them. She helped create Charlene’s Dream, a cancer resource center where women can get information, wigs, and mastectomy bras. Named in memory of Charlene Brady, a friend of Bittner’s and a former AdventHealth Daytona Beach colleague who passed away in 2016 after a brief battle with pancreatic cancer, Bittner facilitates support groups and teaches art classes at Charlene’s Dream.

 a nurse practitioner for children facing bone marrow transplants at the University of Chicago Medicine Comer Children’s Hospital, goes above and beyond in support of patients and their families. She encourages her patients and their family members to call her with any questions or concerns.

 is a practicing nurse of 22 years with 14 years in oncology at Jackson Oncology Associates in Mississippi. She is the Program Chair for the Central Mississippi chapter of ONS. She educates oncology nurses and all clinical support staff and periodically works weekends at the Elvis Presley Memorial Trauma Center in Memphis TN. For many years, she has been a hired speaker for many oncolytic Drug Manufacturers such as Pfizer, Novartis, Eisai, Celgene, Merck, Abbvie, and Taiho. In her spare time, Hammack volunteers for the Cancer League of Jackson and as well as many fund-raising events. Amazingly, her fund-raising efforts have raised more than $100,000 for various cancer charities. As a former high school sprinter, she now runs for a purpose and has completed many long-distance fund-raising events including a 100-mile run in 2017 where she raised $2000 in donations and completed it on her 50th birthday.

The Extraordinary Healer® Award reception will take place April 11 in conjunction with the Oncology Nursing Society’s 44th Annual Congress in Anaheim, California. For more information, click 

This event is supported by Bristol-Myers Squibb, Amgen and Janssen.

The three finalists are oncology nurses who have gone above and beyond for cancer patients.

CURE Magazine Names 2019 Extraordinary Healer Award Finalists

CRANBURY, N.J.--(BUSINESS WIRE)--CURE Media Group, the nation’s leading digital and print media enterprise dedicated to patients and survivors of cancer, welcomes the Foundation for Women’s Cancer (FWC) to the Strategic Alliance Partnership (SAP) program. The partners will collaborate to increase research, education and public awareness about gynecologic cancer risk, prevention, early detection and optimal treatment.

“We are so grateful to partner with the Foundation for Women’s Cancer,” said Michael J. Hennessy Jr., president of MJH Associates Inc., parent company of CURE Media Group. “Through this partnership, we look forward to help supporting the FWC mission and core values to eradicate gynecologic cancers.”

The FWC is a charitable organization formed in 1991 with a vision to end women’s cancer through mission-based programs that support research, education and public awareness of gynecologic cancers. The FWC is the official foundation of the Society of Gynecologic Oncology (SGO), the premier medical specialty society for health care professionals, which will celebrate its 50th anniversary in 2019.

“This partnership with CURE Media Group is an invaluable opportunity,” said the FWC Board Chair, David Mutch, MD, FACOG, of Washington University School of Medicine in St. Louis, MO. “The ability to communicate information about gynecologic cancers — from symptoms to clinical trials – is a vital part of our work and we look forward to seeing these resources reach more people who need them.”

Knowing the importance of bringing awareness to gynecologic cancers, the FWC declared September as Gynecologic Cancer Awareness Month (GCAM) in 1999. This year, the FWC is encouraging survivors, patients, medical staff, advocates and friends to post messages about what they want the public to know about gynecologic cancers using #IWishIKnew and #GCAM throughout the month.

As part of this joint effort, the FWC will be able to share valuable content and awareness campaigns through CURE® magazine, where readers will have access to unprecedented resources, including the latest research, interviews and articles that can help patients with cancer and their caregivers make better-informed decisions. The SAP program is designed to facilitate an open exchange of information among trusted peers, with the goal to improve patient care.

For more information about the SAP program, visit https://www.curetoday.com/advocacy/partners.

CURE Media Group is the leading resource for cancer updates, research and education. It combines a full suite of media products, including an industry-leading website, www.curetoday.com; innovative video programs, such as “CURE Connections®”; a series of widely attended live events; and CURE® magazine, which reaches over 1 million readers. CURE Media Group is part of the Cranbury, New Jersey-based MJH Associates Inc. family of businesses, which includes the acclaimed OncLive® (www.onclive.com) platform of resources for the practicing oncologist. For more information, visit www.curetoday.comor www.mjhassoc.com.

The Foundation for Women’s Cancer (FWC) is a 501(c)(3) nonprofit organization dedicated to increasing research, education and awareness about gynecologic cancer risk, prevention, early detection and optimal treatment. The FWC is the official foundation of the Society of Gynecologic Oncology (SGO). Learn more at foundationforwomenscancer.org.

The Society of Gynecologic Oncology (SGO) is the premier medical specialty society for health care professionals trained in the comprehensive management of gynecologic cancers. As a 501(c)(6) organization, the SGO contributes to the advancement of women’s cancer care by encouraging research, providing education, raising standards of practice, advocating for patients and members, and collaborating with other domestic and international organizations. Learn more at sgo.org.

CURE Media Group Expands Strategic Alliance Partnership Program with the Foundation for Women

CRANBURY, N.J.--(BUSINESS WIRE)--CURE Media Group’s flagship product, 

® magazine, the nation’s leading consumer digital and print media enterprise focused on patients with cancer, will host its monthly Tweet Chat on Thursday, September 27, at 1 p.m. EDT, for readers to ask questions and to facilitate discussions about women’s cancers.

“We look forward to hosting the next edition of the #CureConnect Tweet Chat on September 27, listening to stories and having opening discussions about women’s cancers,” said Michael J. Hennessy Jr., president of MJH Associates Inc., parent company of CURE Media Group.

® welcomes all patients and their loved ones, as well as health care professionals, advocates and nonprofit organizations, to join the chat on women’s cancers — vulvar, uterine, ovarian, breast, cervical and endometrial &mdash; by using the hashtag #CureConnect. Topics will include:

 or find us on Twitter @cure_magazine or on Facebook @curemagazine.

CURE Magazine Hosts #CureConnect Tweet Chat on Women

CRANBURY, N.J.--(BUSINESS WIRE)--CURE Media Group, the nation’s leading digital and print media enterprise dedicated to patients and survivors of cancer, welcomes The Biden Cancer Initiative to the Strategic Alliance Partnership (SAP) program. The partners will collaborate to promote patient education and administration policies for cancer prevention, detection, diagnosis, research and care approaches.

“It’s an honor to team up with The Biden Cancer Initiative,” said Michael J. Hennessy Jr., president of MJH Associates, Inc., parent company of CURE Media Group. “Through this partnership, we look forward to providing key resources to the community on early stages of cancer diagnoses and cancer prevention.”

Founded by former U.S. vice president and second lady (2009-2017), Joe Biden and Dr. Jill Biden, The Biden Cancer Initiative, builds on the Cancer MoonShot program’s ultimate goal to eliminate cancer. This nonprofit organization focuses on reducing disparities in patient outcomes by easing the treatment navigation process of cancer patients and caregivers. Established to overcome the lack of cohesive, comprehensive and timely approach to cancer prevention, detection, diagnosis, research and care, the foundation serves as a guiding force for the cancer community. Additionally, it instills a sense of urgency into cancer research and care systems and redesigning the ways government, academia, private sector and nonprofit organizations join forces to fight cancer.

On Friday, September 21, the Bidens are hosting a national Biden Cancer Community Summit in Washington, D.C. The summit will focus on the patient’s journey from prevention through a cancer diagnosis, treatment through survivorship, and determine what we must do to accelerate progress. As part of this joint effort, The Biden Cancer Initiative will be able to share valuable content through CURE® magazine and its sister publication, American Journal of Managed Care®, where readers will have access to unprecedented content including latest research, interviews and articles that can help cancer patients and policymakers stay informed. The SAP program is designed to facilitate an open exchange of information among trusted peers, the goal of which is to improve patient care.

For more information about the Strategic Alliance Partnership Program, visit https://www.curetoday.com/advocacy/partners.

Sister publication American Journal of Managed Care® will also be a part of this collaboration

CURE Media Group Expands Strategic Alliance Partnership Program with The Biden Cancer Initiative

CRANBURY, N.J.--(BUSINESS WIRE)--CURE® magazine, the nation’s leading consumer digital and print media enterprise focused on patients with cancer, was recently named a finalist in four categories in the Folio: Eddie and Ozzie Awards, the most prestigious and most inclusive awards program in the publishing community.

“It is a tremendous honor that CURE® magazine has been recognized as a finalist in the Folio: Eddie and Ozzie Awards,” said Michael J. Hennessy Jr., president of MJH Associates Inc., parent company of CURE Media Group. “This recognition clearly demonstrates how hard the whole team works to furthering our mission in providing valuable information to patients, caregivers and survivors of cancer.”

Consumer column/blog: I Still Am by Tracy Ahrens

Consumer podcast: A Candid Conversation with Patrick Dempsey by Katie Kosko

Consumer health, single article: Flat, But Not Flattened by Stacy Verner

Consumer (circulation greater than 100 to 500) feature design: Cancer Under Cover by Ray Pelesko (Winter 2018)

Each year, over 2,000 entries in the Folio: Eddie and Ozzie Awards compete across 200 categories that recognize excellence in editorial and design. This year, winners and honorable mentions will be announced during a celebratory gala Tuesday, October 9, from 5:30 to 8:30 p.m. at the New York Hilton Midtown in New York City.

For more information, visit www.foliomag.com/go/2018-eddie-and-ozzie-awards.

CURE Magazine Named 2018 Folio: Eddie & Ozzie Award Finalist in Four Categories

 Media Group, the nation’s leading digital and print media enterprise focused on patients with cancer, has opened nominations for its 2019 Extraordinary Healer® Award for Oncology Nursing. This yearly honor recognizes oncology nurses who have made great strides in the field of oncology or who have demonstrated commendable compassion in patient care. 

“We are excited to be accepting nominations for this year’s Extraordinary Healer® Award for Oncology Nursing and thrilled to recognize another exceptional oncology nurse who makes a real difference in the care of their patients,” said Michael J. Hennessy Jr., president of MJH Associates Inc., parent company of 

Nominations will be accepted through Jan. 1 and can be submitted by current and former patients, caregivers, or peers in the form of a 700- to 1,000-word essay that should reflect the candidate’s outstanding contributions to the field of oncology or in a patient’s life. The selection committee will choose three finalists who will be honored at a gala reception held in conjunction with the Oncology Nursing Society’s 44th Annual Congress, which will take place in April 2019 in Anaheim, California. One nurse ultimately will be recognized with the 2019 Extraordinary Healer® Award for Oncology Nursing.

For more information and to submit a nomination online, visit https://www.curetoday.com/extraordinaryhealer.

CURE Media Group Seeks Nominations for the 2019 Extraordinary Healer Award for Oncology Nursing

® magazine, the nation’s leading consumer digital and print media enterprise focused on patients with cancer, published its most recent Rare Cancers issue, announced Michael J. Hennessy Jr., president of MJH Associates Inc., parent company of 

In making the announcement, Michael J. Hennessy, Jr said, “Our Rare Cancers issue hits close to home, as we are the leading resource for cancer updates, research and education within the cancer community. It is our mission to continue our efforts in providing the most up-to-date research and studies to cancer patients, survivors and their caregivers.”

Although the oncology field continues to advance in many ways, studying a rare cancer — defined by the American Cancer Society as fewer than six cases per 100,000 people each year &mdash; presents a challenge due to the rarity of these diseases.

In this issue, CURE® focuses its cover story, Advances and Combinations Raise Sights on Uveal Melanoma, on the clinical trials that seek to discover new ways to attack cancer of the eye, limit metastasis and prevent recurrence of the disease. Two patients share their very different journeys with uveal melanoma — one woman developing metastasis to her liver and brain &mdash; and how they are doing today.

Turning the Tide. Innovations in drug development, surgery, radiation and clinical trials have investigators hard at work in glioblastoma.

Waldenstrom Macroglobulinemia: The Discovery and What Lies Ahead. This incurable rare cancer of the lymphatic system has seen improvements, but what is the best strategy for treating patients with the disease?

Training Through Treatments: Pro Runner Doesn’t Let Rare Cancer Slow Her Down. After receiving a diagnosis of adenoid cystic carcinoma, Gabriele Grunewald wanted to help others and founded Brave Like Gabe.

In addition, the magazine offers news and updates within the rare cancer space, from a Food and Drug approval in thyroid cancer to clinical trials in pediatric cancers and new targeted therapies for a mantle cell lymphoma prognosis.

To read more from the Rare Cancers Special Issue, visit curetoday.com.

CURE Magazine Releases Its Rare Cancers Specialty Issue

 Media Group, the nation’s leading digital and print media enterprise focused on cancer patients, is proud to announce that Scott Hamilton, Olympic champion, author and cancer survivor, will be the guest speaker for the 6thAnnual MPN Heroes® recognition ceremony. The event honors individuals or organizations that have made a difference in the field of blood cancers known as myeloproliferative neoplasms (MPNs). This year’s program will take place on Friday, November 30, at the Hard Rock Hotel San Diego.

“We are thrilled to have Scott Hamilton as the guest speaker for this celebration,” said Michael J. Hennessy Jr., President of MJH Associates Inc., parent company of 

 Media Group. “As a cancer survivor and longtime advocate for cancer research and education, Scott’s values are perfectly aligned with the core principles of the MPN Heroes recognition program. Together, we look forward to celebrating the accomplishments of these heroes at the MPN Heroes recognition ceremony.”

Inspired by his own journey with testicular cancer and pituitary brain tumors, and the loss of his mother to cancer, Hamilton launched the Scott Hamilton CARES (Cancer Alliance for Research, Education and Survivorship) Foundation. This nonprofit organization provides education, supports research and hosts survivorship programs for patients and caregivers, and works to fund innovative therapies and treatment. Hamilton serves on the board of directors of the Provision Center for Proton Therapy in Knoxville, Tennessee.

The MPN Heroes Recognition Program is made possible by the generous support of Incyte Corporation, a global biopharmaceutical company that discovers and develops novel medicines to meet serious unmet medical needs in oncology and other diseases. The program honors those who are empowering patients with MPNs and making a difference in the MPN community. The honorees are nominated by patients and caregivers for their extraordinary contributions and dedication.

To reserve a seat at the event, visit https://www.curetoday.com/mpnheroes.

Press Releases